Liu X - Search Results

1

Rapid identification of novel indolylarylsulfone derivatives as potent HIV-1 NNRTIs via miniaturized CuAAC click-chemistry-based combinatorial libraries.

Gao P, Song S, Pannecouque C, De Clercq E, Zhan P, Liu X. Gao P, et al. Among authors: liu x. RSC Med Chem. 2024 Oct 15. doi: 10.1039/d4md00469h. Online ahead of print. RSC Med Chem. 2024. PMID: 39421538 Free PMC article.

2

Synthesis and anti-HIV evaluation of the novel 2-(m-chlorobenzyl)-4-substituted-7-methyl-1, 1, 3-trioxo-pyrazolo[4, 5-e] [1, 2, 4]thiadiazines.

Yan RZ, Liu XY, Xu WF, Pannecouque C, Witvrouw M, De Clercq E. Yan RZ, et al. Arch Pharm Res. 2006 Nov;29(11):957-62. doi: 10.1007/BF02969278. Arch Pharm Res. 2006. PMID: 17146963

3

Design, synthesis, and biological activities of novel Ligustrazine derivatives.

Cheng XC, Liu XY, Xu WF, Guo XL, Ou Y. Cheng XC, et al. Bioorg Med Chem. 2007 May 15;15(10):3315-20. doi: 10.1016/j.bmc.2007.03.033. Epub 2007 Mar 15. Bioorg Med Chem. 2007. PMID: 17383884

4

Synthesis of novel derivatives of 4-amino-3-(2-furyl)-5-mercapto-1,2,4-triazole as potential HIV-1 NNRTIs.

Wu J, Liu X, Cheng X, Cao Y, Wang D, Li Z, Xu W, Pannecouque C, Witvrouw M, De Clercq E. Wu J, et al. Among authors: liu x. Molecules. 2007 Aug 22;12(8):2003-16. doi: 10.3390/12082003. Molecules. 2007. PMID: 17960101 Free PMC article.

5

Synthesis and anti-HIV evaluation of novel 1,3-disubstituted thieno[3,2-c][1,2,6]thiadiazin-4(3H)-one 2,2-dioxides(TTDDs).

Lin Y, Liu X, Yan R, Li J, Pannecouque C, Witvrouw M, De Clercq E. Lin Y, et al. Among authors: liu x. Bioorg Med Chem. 2008 Jan 1;16(1):157-63. doi: 10.1016/j.bmc.2007.10.013. Epub 2007 Oct 10. Bioorg Med Chem. 2008. PMID: 17964796 Free article.

6

Synthesis and anti-HIV activity evaluation of novel 2,4-disubstituted 7-methyl-1,1,3-trioxo-2,4-dihydro-pyrazolo-[4,5-e][1,2]thiadiazines.

Liu XY, Yan RZ, Wang Y, Zhan P, De Clercq E, Pannecouque C, Witvrouw M, Molina MT, Vega S. Liu XY, et al. Arch Pharm (Weinheim). 2008 Apr;341(4):216-22. doi: 10.1002/ardp.200700216. Arch Pharm (Weinheim). 2008. PMID: 18266290

7

Recent advances in antiviral activity of benzo/heterothiadiazine dioxide derivatives.

Zhan P, Liu X, De Clercq E. Zhan P, et al. Among authors: liu x. Curr Med Chem. 2008;15(15):1529-40. doi: 10.2174/092986708784638898. Curr Med Chem. 2008. PMID: 18537628 Review.

8

1,2,3-Thiadiazole thioacetanilides as a novel class of potent HIV-1 non-nucleoside reverse transcriptase inhibitors.

Zhan P, Liu X, Cao Y, Wang Y, Pannecouque C, De Clercq E. Zhan P, et al. Among authors: liu x. Bioorg Med Chem Lett. 2008 Oct 15;18(20):5368-71. doi: 10.1016/j.bmcl.2008.09.055. Epub 2008 Sep 18. Bioorg Med Chem Lett. 2008. PMID: 18824350

9

Recent advances in the research of HIV-1 RNase H inhibitors.

Yu F, Liu X, Zhan P, De Clercq E. Yu F, et al. Among authors: liu x. Mini Rev Med Chem. 2008 Oct;8(12):1243-51. doi: 10.2174/138955708786141052. Mini Rev Med Chem. 2008. PMID: 18855738 Review.

10

Cessation of HIV-1 transcription by inhibiting regulatory protein Rev-mediated RNA transport.

Cao Y, Liu X, De Clercq E. Cao Y, et al. Among authors: liu x. Curr HIV Res. 2009 Jan;7(1):101-8. doi: 10.2174/157016209787048564. Curr HIV Res. 2009. PMID: 19149559 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

135,089 results

Search Page

Filters